Alivus Life Sciences Limited has informed the Exchange about Link of Recording
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed the stock exchanges that the audio recording of its Q1 FY2025-26 earnings call, held on August 2, 2025, has been uploaded to the company's website. This is a routine regulatory disclosure filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30 and 46). No new financial figures, guidance, or strategic updates are included in the filing itself. Shareholders who want to hear management's commentary can access the recording via the link provided.
No direct impact on the stock price — this is a standard compliance filing confirming the availability of the earnings call recording. Investors should listen to the recording for any management guidance or commentary on Q1 performance.